<DOC>
	<DOCNO>NCT02453490</DOCNO>
	<brief_summary>This study multicenter , randomization , open control study evaluate efficacy safety Raltitrexed-based chemotherapy 5-fluorouracil-based chemotherapy peri-operative treatment patient Liver Metastasis From colorectal cancer ( CRC ) .</brief_summary>
	<brief_title>Compare Efficacy Safety Raltitrexed-based 5fu-based Neoadjuvant Chemotherapy Colorectal Liver Metastasis</brief_title>
	<detailed_description>The contrast analysis separately do Raltitrexed plus oxaliplatin 5-fluorouracil plus oxaliplatin ; Raltitrexed plus irinotecan 5-fluorouracil plus irinotecan.To investigate objective response rate , R0 resection rate , early tumor shrinkage （ETS）and depth response ( DPR ) safety profile .</detailed_description>
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<mesh_term>Liver Neoplasms</mesh_term>
	<mesh_term>Oxaliplatin</mesh_term>
	<mesh_term>Irinotecan</mesh_term>
	<mesh_term>Raltitrexed</mesh_term>
	<mesh_term>Fluorouracil</mesh_term>
	<criteria>1 . Histologically confirm chinese colorectal cancer patient image detection confirm liver metastasis 2. previously treatment liver metastasis Primary tumor remove last additional chemotherapy one year 3 . Age of≥18 ≤75 4 . Adequate organ function , determine normal bone marrow function ( absolute neutrophil count2 x 109/L , platelet 100 x 109/L , White blood cell 4 x 109/L ) , liver function ( serum bilirubin ≤ 2.5 x ULN , serum transaminase ≤2 . 5x ULN ) 5 . ECOG≤1 6 . Life Expectancy＞6months 7 . Signed write informed consent 8 . Expected adequacy followup 1 . Lesion small ass image 2 . Extrahepatic metastasis 3 . Any anticancer chemotherapy development within 4 week prior study entry 4 . Concurrent uncontrolled illness infection 5 . Be allergic medicine study 6 . Pregnant nursing patient 7 . Fertile woman ( &lt; 2 year last menstruation ) men childbearing potential willing use effective mean contraception . 8 . Not willing incapable comply study visit assessment 9 . Evidence disease , metabolic dysfunction , physical examination find laboratory find give reasonable suspicion disease condition put patient high risk treatmentrelated complication .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Colorectal Cancer</keyword>
	<keyword>liver metastasis</keyword>
	<keyword>neoadjuvant chemotherapy</keyword>
</DOC>